<VariationArchive RecordType="classified" VariationID="9419" VariationName="NC_000009.12:g.21977568_21999392del" VariationType="Deletion" Accession="VCV000009419" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24458" VariationID="9419">
      <GeneList>
        <Gene Symbol="LOC130001607" FullName="ATAC-STARR-seq lymphoblastoid silent region 19814" GeneID="130001607" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21995045" stop="21995244" display_start="21995045" display_stop="21995244" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="CDKN2A" FullName="cyclin dependent kinase inhibitor 2A" GeneID="1029" HGNC_ID="HGNC:1787" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21967752" stop="21995324" display_start="21967752" display_stop="21995324" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21967750" stop="21994489" display_start="21967750" display_stop="21994489" Strand="-" />
          </Location>
          <OMIM>600160</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="CDKN2B-AS1" FullName="CDKN2B antisense RNA 1" GeneID="100048912" HGNC_ID="HGNC:34341" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21994791" stop="22128142" display_start="21994791" display_stop="22128142" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21994789" stop="22121095" display_start="21994789" display_stop="22121095" Strand="+" />
          </Location>
          <OMIM>613149</OMIM>
        </Gene>
        <Gene Symbol="LOC130001606" FullName="ATAC-STARR-seq lymphoblastoid silent region 19813" GeneID="130001606" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21994465" stop="21994724" display_start="21994465" display_stop="21994724" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000009.12:g.21977568_21999392del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21977568" stop="21999392" display_start="21977568" display_stop="21999392" variantLength="21825" />
      </Location>
      <OtherNameList>
        <Name>EXON 1-BETA DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.21977568_21999392del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.21977568_21999392del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600160.0012" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for the allelic variant 600160.0012 from the sequence across the breakpoint in Figure 5 of the paper by Randerson-Moor et al., 2001 (PubMed 11136714).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.12:g.21977568_21999392del AND Melanoma and neural system tumor syndrome" Accession="RCV000010026" Version="2">
        <ClassifiedConditionList TraitSetID="2590">
          <ClassifiedCondition DB="MedGen" ID="C1835042">Melanoma and neural system tumor syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11136714</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5472" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melanoma astrocytoma syndrome</ElementValue>
                <XRef ID="Melanoma+astrocytoma+syndrome/4577" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melanoma and neural system tumor syndrome</ElementValue>
                <XRef ID="MONDO:0007967" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8468" />
                <XRef ID="8468" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="252206" DB="Orphanet" />
              <XRef ID="C1835042" DB="MedGen" />
              <XRef ID="MONDO:0007967" DB="MONDO" />
              <XRef Type="MIM" ID="155755" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30247" SubmissionDate="2013-04-02" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600160.0012_MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME" title="CDKN2A, EXON 1-BETA DEL_MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME" />
        <ClinVarAccession Accession="SCV000030247" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Randerson-Moor et al. (2001) described a family characterized by multiple melanoma and neural cell tumors (155755) segregating with a germline deletion of the p14(ARF)-specific exon 1-beta of CDKN2A. The deletion was approximately 14 kb and did not affect the coding or minimal promoter sequences of either CDKN2A or CDKN2B.</Attribute>
              <Citation>
                <ID Source="PubMed">11136714</ID>
              </Citation>
              <XRef DB="OMIM" ID="155755" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <Name>CDKN2A, EXON 1-BETA DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EXON 1-BETA DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600160.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30247" TraitType="Disease" MappingType="Name" MappingValue="MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1835042" Name="Melanoma and neural system tumor syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

